Health Care & Life Sciences » Biotechnology | Neuren Pharmaceuticals Ltd.

Neuren Pharmaceuticals Ltd.

Neuren Pharmaceuticals Ltd.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$84.6 M
Shares Outstanding
100.67 M
Public Float
-
Neuren Pharmaceuticals Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD121.23 M
Shares Outstanding
103.17 M
Public Float
63.07 M

Profile

Address
697 Burke Road
Camberwell Victoria (VIC) 3124
Australia
Employees -
Website http://www.neurenpharma.com
Updated 07/08/2019
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment and neurodegenerative disorders. The company was founded on December 17, 2001 and is headquartered in Melbourne, Australia. .

Financials

View All
Created with Highcharts 5.0.14Neuren Pharmaceuticals Ltd.Net Income. Fiscal year is January-December. All values AUD Thousands.10 43610 4368 2978 29713 39713 39712 01412 0143 2883 2883 0733 07320132014201520162017201802.5k5k7.5k10k12.5k15k

Richard Spencer Treagus
Executive Chairman
Lawrence Glass
Executive Director & Chief Science Officer